Therapeutic Antibodi - Directors S/holding-Amendment

RNS No 6002t
THERAPEUTIC ANTIBODIES INC
12th November 1998

Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
MARTIN S BROWN (AMENDMENT TO NOTIFICATION GIVEN ON 10 NOVEMBER 1998)

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR MAMED IN 2 ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
MARTIN S BROWN

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
-

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
ADDITIONAL CONVERSION OF DEBT INTO EQUITY

7   Number of shares/amount of stock acquired:
736,811

8   Percentage of issued class:
1.42

9   Number of shares/amount of stock disposed:
-

10  Percentage of issued class:
-

11  Class of security:
SHARES OF COMMON STOCK OF US $0.001

12  Price per share:
40P

13  Date of transaction:
9.11.98

14  Date company informed:
9.11.98

15  Total holding following this notification:
3,761,224

16  Total percentage holding of issued class following this notification:
7.23%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
-

18  Period during which or date on which exercisable:
-

19  Total amount paid (if any) for grant of the option:
-

20  Description of shares or debentures involved: class, number:
-

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
-

22  Total number of shares or debentures over which options held following
this notification:
-

23  Contact name for queries:
SAUL KOMISAR

24  Contact telephone number:
001 615 963 4529

25  Name of company official responsible for making notification:
PHIL WALKER, WESTLB PANMURE LIMITED:  0171 638 4010

Additional Information:
This notification covers the conversion of US$500,000 into shares of common
stock at 40p per share which was disclosed in the listing particulars dated
26.10.98 but omitted from the notification on 10.11.98.


END


RDSNFKFAFAXPFFN

Becket Invest (LSE:TAB)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024